Correlation Between Dyadic International and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Molecular Partners AG, you can compare the effects of market volatilities on Dyadic International and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Molecular Partners.
Diversification Opportunities for Dyadic International and Molecular Partners
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dyadic and Molecular is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Dyadic International i.e., Dyadic International and Molecular Partners go up and down completely randomly.
Pair Corralation between Dyadic International and Molecular Partners
Given the investment horizon of 90 days Dyadic International is expected to generate 1.08 times more return on investment than Molecular Partners. However, Dyadic International is 1.08 times more volatile than Molecular Partners AG. It trades about 0.43 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.08 per unit of risk. If you would invest 109.00 in Dyadic International on August 28, 2024 and sell it today you would earn a total of 82.00 from holding Dyadic International or generate 75.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyadic International vs. Molecular Partners AG
Performance |
| Timeline |
| Dyadic International |
| Molecular Partners |
Dyadic International and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyadic International and Molecular Partners
The main advantage of trading using opposite Dyadic International and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world |